What "As Natural As Possible" Actually Means: And Why It Is Point One
- Christian Svantesson
- för 1 dag sedan
- 4 min läsning
Every supplement brand uses the word natural. It appears on labels, in marketing copy, and in brand positioning across the entire category. It is also one of the least regulated terms in the industry. It means, in practice, whatever the brand needs it to mean.
CuratedFit's first criterion is different. Not because the words are different. Point one of the standard reads "as natural as possible." The difference is because the question behind it is different.
We are not asking whether a product sounds natural. We are asking where the active ingredient came from, and how it got from there to the capsule.
The question the label does not answer
Pick up almost any supplement and read the ingredients list. You will find a compound name (ascorbic acid, alpha-tocopherol, creatine monohydrate, beta-carotene) followed by a quantity. What the label does not tell you is whether that compound was extracted from a natural source or assembled in a laboratory from industrial chemical precursors.
Both versions carry the same name. Both produce measurable short-term effects. Both can legally appear on a label without any indication of how they were produced.
That gap, between what the label says and what the label does not say, is where point one of the CuratedFit standard does its work.
Biological production versus chemical synthesis
The distinction we apply is straightforward in principle, though it is rarely made visible to consumers in practice.
A naturally derived active ingredient originates from a biological system. It is extracted, concentrated, or standardized from a real food, plant, or biological material. The process may be industrial in scale. But the origin of the molecule is biological.
A synthetically produced active ingredient is chemically assembled from industrial precursors. The molecule may be structurally identical, or near-identical, to the naturally occurring version. But it did not come from a plant, a food, or a living organism. It came from a chemical reaction between non-biological starting materials.
Vitamin C is a useful illustration. Ascorbic acid derived from acerola cherry or from fermented corn starch is biologically produced. Ascorbic acid synthesized via the Reichstein process, the industrial method used for the majority of vitamin C supplements on the market, begins with glucose that is chemically converted through several synthetic steps. The end molecule is structurally similar. The origin is not.
For most synthetic compounds, the industry's answer to this distinction is: the molecule is the same, therefore it behaves the same. That argument has a logic to it. It also has a history.
What happens when you remove the structure
Nutrition science spent decades operating on a simple assumption: a substance is responsible for the value it delivers, and the surrounding structure it arrives in is incidental packaging. Identify the active compound. Isolate it. Deliver it. The benefit follows.
That assumption has been tested at population scale. It has not always held up.
Fructose is the most documented case. Present in every piece of fruit and long considered benign, it entered the food supply in isolated, concentrated form at levels no whole fruit diet ever produced, stripped of the fiber, water, and co-factors that always accompanied it. What followed, over twenty-five years of population-scale consumption, was a rise in non-alcoholic fatty liver disease now seen in children with no history of alcohol consumption. The short-term studies had shown nothing alarming.
Beta-carotene produced a similar lesson inside clinical research. Observational data suggested that people eating diets high in beta-carotene had lower cancer rates. Researchers isolated it and ran large controlled trials expecting to confirm the benefit. Several found increased lung cancer risk among smokers taking isolated beta-carotene supplements. The compound did not behave the way the food data predicted.
The surrounding structure had been doing something. Nobody knew what it was until it was removed.
Why this matters for supplements specifically
The supplement industry's response to the natural versus synthetic question is almost always the same: safety data exists, the molecule works, the dose is controlled.
All of that may be true. What it does not address is the question many conscious consumers still ask: where did the ingredient come from, how was it produced, and what was removed along the way?
Our position is simpler. Origin matters, production method matters, and consumers deserve to know both. Where a naturally derived option exists, we prefer it, not as a claim about safety, but as an application of the standard we have chosen to apply.
That is point one of the standard. It is first because it closes the most significant gap between what the market sells and what a conscious consumer would choose if they had the full picture.
What passes and what does not
Under point one, a product passes if its active ingredients originate from a biological system. Fermented nutrients pass. Cold-processed whole food concentrates pass. Plant and herb extracts pass. Biological processes such as bacterial fermentation used to produce B vitamins pass. The molecule is produced by a living organism, which is how it exists in food.
Products whose primary active compounds are chemically synthesized from industrial precursors do not pass, regardless of safety profile, efficacy data, or brand reputation. The question is not whether the compound works. The question is where it came from.
Minor additives such as stabilizers, natural flavorings, and preservatives used in functionally necessary quantities are treated separately. They are flagged transparently in every review and assessed against point three of the standard. They are a different category from a synthetically produced active ingredient, and they are not the reason a product passes or fails point one.
Why most products fail here
The majority of the supplement market is built on synthetic production. Not because natural derivation is impossible. It is not. But because chemical synthesis is cheaper, more consistent at scale, and produces a molecule the regulatory framework treats as equivalent.
From a manufacturing perspective, that logic is sound. From the perspective of a consumer who wants to know what they are actually putting into their body and where it came from, the regulatory equivalence does not answer the question.
Point one exists because that question deserves an answer. Most products cannot provide one clearly. It is a market that has never been asked to make origin visible. CuratedFit asks.
Kommentarer